Gamma Investing LLC Xtl Biopharmaceuticals LTD Transaction History
Gamma Investing LLC
- $1.99 Trillion
- Q4 2025
A detailed history of Gamma Investing LLC transactions in Xtl Biopharmaceuticals LTD stock. As of the latest transaction made, Gamma Investing LLC holds 12,887 shares of XTLB stock, worth $11,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,887Holding current value
$11,856% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XTLB
# of Institutions
7Shares Held
439KCall Options Held
0Put Options Held
0-
Noked Capital LTD Tel Aviv, L3199KShares$182,9760.02% of portfolio
-
Noked Israel LTD Ramat Hasharon, L3199KShares$182,9760.04% of portfolio
-
Rhumbline Advisers Boston, MA17.3KShares$15,8800.0% of portfolio
-
Morgan Stanley New York, NY10KShares$9,2100.0% of portfolio
-
Ubs Group Ag763Shares$7010.0% of portfolio
About XTL BIOPHARMACEUTICALS LTD
- Ticker XTLB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,449,060
- Market Cap $5.01M
- Description
- XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Ye...